Article

Microbiome landscape and association with response to immune checkpoint inhibitors in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN

2023-08-16

Abstract excerpt

<title>Abstract</title> <p>Although the gut microbiome is associated with cancer development and progression, little is known about the effects of the gut microbiome landscape and the efficacy of immune checkpoint inhibitors (ICIs) across cancers. We investigated the association between the microbiome, clinical features, and ICIs efficacy across cancer types in a large nationwide screening project for solid tumor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5027bbb-9083-5c11-a4f1-964513efbc00
DOI: 10.21203/rs.3.rs-3255461/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Microbiome landscape and association with response to immune checkpoint inhibitors in advanced solid tumors: SCRUM-Japan MONSTAR-SCREENDOI 10.21203/rs.3.rs-3255461/v1Read

Catalog of gut microbiota alterations associated with anticancer therapies across multiple cancer typesSemantic proximity Read

A review on the role of gut microbiota in immune checkpoint blockade therapy for cancerSemantic proximity Read

Tumor-Associated Microbiome: Where Do We Stand?Semantic proximity Read

Complex interactions between the microbiome and cancer immune therapySemantic proximity Read

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in CancerSemantic proximity Read

Gut microbial structural variation associates with immune checkpoint inhibitor responseSemantic proximity Read

Intra-tumor microbiome-based tumor survival indices predict immune interaction and drug sensitivity on pan-cancer scaleSemantic proximity Read

Microbiome influencers of checkpoint blockade–associated toxicitySemantic proximity Read

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumorsSemantic proximity Read

Gut microbiome in modulating immune checkpoint inhibitorsSemantic proximity Read

The Microbiome Matters: Its Impact on Cancer Development and Therapeutic ResponsesSemantic proximity Read

Microbial Architects of Malignancy: Exploring the Gut Microbiome’s Influence in Cancer Initiation and ProgressionSemantic proximity Read